January 8, 2019
Announcement no. 1
Corrected Financial Calendar 2019
| DATE 2019 | DESCRIPTION |
January 25, 2019 | Quiet Period prior to the Annual Report begins (4 weeks) |
| February 1, 2019 | Deadline for shareholder proposals - Annual General Meeting |
| February 22, 2019 | Annual Report 2018 & Investor Meeting |
| March 18, 2019 | Annual General Meeting |
| April 25, 2019 | Quiet Period prior to the Interim Report begins (2 weeks) |
| May 9, 2019 | Interim Report – 3 months 2019 & Investor Meeting |
| August 1, 2019 | Quiet Period prior to the Interim Report begins (2 weeks) |
| August 15, 2019 | Interim Report – 6 months 2019 & Investor Meeting |
| October 24, 2019 | Quiet Period prior to the Interim Report begins (2 weeks) |
| November 7, 2019 | Interim Report – 9 months 2019 & Investor Meeting |
For further information, please contact:
Gry Husby Larsen, General Counsel
Telephone +45 4529 0000, e-mail investor@bioporto.com
About BioPorto
BioPorto is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. BioPorto has its headquarters in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange.
Attachment
